|Articles|September 7, 2017
- Pharmaceutical Commerce - September/October 2017
Cold Chain 2017 Directory
Advertisement
Articles in this issue
about 8 years ago
Patient data saves livesabout 8 years ago
MDM’s growing role in running healthcare businessesabout 8 years ago
The power of strategic data standardizationabout 8 years ago
2017 Cold Chain Outlookabout 8 years ago
Is the opioid crisis a national emergency?about 8 years ago
It’s time for an industry guideline on patient support servicesabout 8 years ago
A conversation with Greg Flynn, Ashfield Healthcare USabout 8 years ago
LogiPharma meeting highlights digital transformationabout 8 years ago
Drug development in rare diseasesNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
4
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
5
